Meeting of the Healthcare Infection Control Practices Advisory Committee, 33353-33354 [2024-09090]
Download as PDF
<![CDATA[
33353
Federal Register / Vol. 89, No. 83 / Monday, April 29, 2024 / Notices
clinic characteristics; program reach;
CRC screening practices and outcomes;
clinics’ quality improvement and
monitoring activities; EBI
implementation, and additional factors
that affect EBI implementation over
time. The Quarterly Program Update is
administered in the month following
each program quarter (i.e., October,
January, April, July) and collects
standardized recipient-level information
on aspects of program management,
including: quarterly program
expenditures, current staff vacancies,
program successes and challenges,
current TA needs, and the effect of
COVID–19 on CRCCP implementation at
the recipient level. These data are
collected quarterly to facilitate rapid
reporting of programmatic information
to support CDC program consultants in
providing tailored and meaningful TA.
This information collection enables
CDC to gauge progress in meeting
CRCCP program goals and monitor
implementation activities, evaluate
outcomes, and identify recipients’ TA
needs. In addition, data collected will
inform program improvement and help
identify successful activities that need
to be maintained, replicated, or
expanded. OMB approval is requested
for three years. The total estimated
annualized burden is 760 hours. There
is no cost to respondents other than
their time to participate.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
CRCCP Recipients .........................................
CRCCP Annual Awardee Survey ..................
CRCCP Clinic-level Information Collection Instrument.
CRCCP Quarterly Program Update ...............
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–09145 Filed 4–26–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Meeting of the Healthcare Infection
Control Practices Advisory Committee
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention announces the following
meeting for the Healthcare Infection
Control Practices Advisory Committee
(HICPAC). This virtual meeting is open
to the public, limited only by the
number of audio and web conference
lines (500 audio and web conference
lines are available). Time will be
available for public comment.
Registration is required.
DATES: The meeting will be held on June
6, 2024, from 9 a.m. to 5 p.m., EDT, and
June 7, 2024, 9 a.m. to 12 p.m., EDT.
ADDRESSES: To register for this web
conference, please go to: www.cdc.gov/
hicpac. All registered participants will
receive the meeting link and
instructions shortly before the meeting.
SUMMARY:
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
respondents
Type of respondent
VerDate Sep<11>2014
20:54 Apr 26, 2024
Jkt 262001
Please click the link below to join the
June 6 webinar: https://
cdc.zoomgov.com/j/1619798307?
pwd=cmdUT3lFNHFCN
itXZElUdkdnZDRmQT09.
Passcode: fHTc=?7n.
Please click the link below to join the
June 7 Webinar: https://
cdc.zoomgov.com/j/1615598629?
pwd=Ny9pcjhROGR2dGZNeUlmaTQv
QWZxZz09.
Passcode: 8rLxq?*f.
FOR FURTHER INFORMATION CONTACT:
Sydnee Byrd, M.P.A., HICPAC, Division
of Healthcare Quality Promotion,
NCEZID, CDC, 1600 Clifton Road NE,
Mailstop H16–3, Atlanta, Georgia
30329–4027, Telephone: (404) 718–
8039; Email: hicpac@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion (DHQP), the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
the Director, CDC, and the Secretary,
Department of Health and Human
Services, regarding (1) the practice of
healthcare infection prevention and
control; (2) strategies for surveillance,
prevention, and control of infections,
antimicrobial resistance, and related
events in settings where healthcare is
provided; and (3) periodic updating of
CDC guidelines and other policy
statements regarding prevention of
healthcare-associated infections and
healthcare-related conditions.
Matters to be Considered: The agenda
will include the following updates: The
Healthcare Personnel Guideline
Workgroup; Isolation Precautions
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hr)
35
35
1
24
15/60
50/60
35
4
22/60
Guideline Workgroup; NHSN
workgroup; and Dental Unit Waterlines
Guideline Update. Agenda items are
subject to change.
Public Participation
Oral Public Comment: This meeting
will include time for members of the
public to make an oral comment.
Priority will be given to individuals
who submit a request to make an oral
public comment before the meeting
according to the procedures below: All
persons interested in making an oral
public comment at the June 6–7, 2024
HICPAC meeting must submit a request
between May 13, 2024, and May 24,
2024, at https://www.cdc.gov/hicpac/
meeting.html no later than 11:59 p.m.,
EDT, May 22, 2024, according to the
instructions provided on the HICPAC
website. If the number of persons
requesting to speak is greater than can
be reasonably accommodated during the
scheduled time, CDC will conduct a
lottery draw to determine the speakers
for the scheduled public comment
session. CDC staff will notify
individuals regarding their request to
speak by email on May 27, 2024.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
E:\FR\FM\29APN1.SGM
29APN1
33354
Federal Register / Vol. 89, No. 83 / Monday, April 29, 2024 / Notices
Docket Number. All relevant comments
received in conformance with the
https://www.regulations.gov, suitability
policy will be posted without change to
https://www.regulations.gov, including
any personal information provided. For
access to the docket to read background
documents or comments received, go to
https://www.regulations.gov. Written
public comments submitted up to 72
hours prior to the ACD meeting will be
provided to ACD members before the
meeting. Written comments received in
advance of the meeting will be included
in the official record of the meeting.
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–09090 Filed 4–26–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
FOR FURTHER INFORMATION CONTACT:
[Docket No. CDC–2024–0034]
Meeting of the Advisory Committee to
the Director (ACD), Centers for Disease
Control and Prevention
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting and request
for comment.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting for the Advisory
Committee to the Director, Centers for
Disease Control and Prevention (ACD,
CDC). This meeting is open to the
public. The meeting will be webcast live
via the World Wide Web.
DATES: The meeting will be held on June
6, 2024, from 10 a.m. to 3 p.m., EDT
(times subject to change).
The public may submit written
comments from April 29, 2024 through
May 24, 2024.
ADDRESSES: No registration is required
to view the meeting via the World Wide
Web. Information for accessing the
webcast will be available at https://
www.cdc.gov/about/advisorycommittee-director/.
Written comments: You may submit
comments identified by Docket No.
CDC–2024–0034 by either of the
following methods below. Do not
submit comments for the docket by
email. CDC does not accept comments
for the docket by email.
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Tiffany Brown, JD MPH,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE,
Mailstop H21–10, Atlanta, Georgia
30329–4027. Attn: Docket number CDC–
2024–0034.
Instructions: All submissions received
must include the Agency name and
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
20:54 Apr 26, 2024
Jkt 262001
Tiffany Brown, JD MPH, Centers for
Disease Control and Prevention, Office
of the Chief of Staff, 1600 Clifton Road
NE, Mailstop H21–10, Atlanta, Georgia
30329–4027, Telephone: (404) 498–
6655; Email Address: ACDirector@
cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Advisory Committee to
the Director, CDC, shall (1) make
recommendations to the Director
regarding ways to prioritize the
activities of the agency in alignment
with the CDC Strategic Plan required
under section 305(c); H.R. 2617–1252;
(2) advise on ways to achieve or
improve performance metrics in relation
to the CDC Strategic Plan, and other
relevant metrics, as appropriate; (3)
provide advice and recommendations
on the development of the Strategic
Plan, and any subsequent updates, as
appropriate; (4) advise on grant,
cooperative agreements, contracts, or
other transactions, as applicable; (5)
provide other advice to the Director, as
requested, to fulfill duties under
sections 301 and 311; and (6) appoint
subcommittees. The committee
recommends ways to prioritize CDC’s
activities, improve results, and address
health disparities. It also provides
guidance to help CDC work more
effectively with its various private and
public sector constituents to make
health protection a practical reality.
Matters to be Considered: The agenda
will include an update on CDC
priorities from the CDC Director,
discussions on CDC’s work to address
equity and social determinants of
health, lab readiness and response
improvement efforts, programmatic
updates, and updates from the ACD
Data and Surveillance Workgroup and
the Communications and Public
Engagement Workgroup. Agenda items
are subject to change as priorities
dictate.
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
Public Participation
Interested persons or organizations
are invited to participate by submitting
written views, recommendations, and
data. Please note that comments
received, including attachments and
other supporting materials, are part of
the public record and are subject to
public disclosure. Comments will be
posted on https://www.regulations.gov.
Therefore, do not include any
information in your comment or
supporting materials that you consider
confidential or inappropriate for public
disclosure. If you include your name,
contact information, or other
information that identifies you in the
body of your comments, that
information will be on public display.
CDC will review all submissions and
may choose to redact, or withhold,
submissions containing private or
proprietary information such as Social
Security numbers, medical information,
inappropriate language, or duplicate/
near duplicate examples of a mass-mail
campaign. CDC will carefully consider
all comments submitted into the docket.
Written Public Comment: The docket
will be opened to receive written
comments on April 29, 2024 through
May 24, 2024.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–09081 Filed 4–26–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3462–PN]
Medicare Program; Application by The
Compliance Team (TCT) for Continued
CMS Approval of its Home Infusion
Therapy (HIT) Accreditation Program
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice with request for
comment.
AGENCY:
E:\FR\FM\29APN1.SGM
29APN1
]]>Agencies
[Federal Register Volume 89, Number 83 (Monday, April 29, 2024)]
[Notices]
[Pages 33353-33354]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-09090]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Meeting of the Healthcare Infection Control Practices Advisory
Committee
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention announces the following
meeting for the Healthcare Infection Control Practices Advisory
Committee (HICPAC). This virtual meeting is open to the public, limited
only by the number of audio and web conference lines (500 audio and web
conference lines are available). Time will be available for public
comment. Registration is required.
DATES: The meeting will be held on June 6, 2024, from 9 a.m. to 5 p.m.,
EDT, and June 7, 2024, 9 a.m. to 12 p.m., EDT.
ADDRESSES: To register for this web conference, please go to:
www.cdc.gov/hicpac. All registered participants will receive the
meeting link and instructions shortly before the meeting. Please click
the link below to join the June 6 webinar: https://cdc.zoomgov.com/j/1619798307?pwd=cmdUT3lFNHFCNitXZElUdkdnZDRmQT09.
Passcode: fHTc=?7n.
Please click the link below to join the June 7 Webinar: https://cdc.zoomgov.com/j/1615598629?pwd=Ny9pcjhROGR2dGZNeUlmaTQvQWZxZz09.
Passcode: 8rLxq?*f.
FOR FURTHER INFORMATION CONTACT: Sydnee Byrd, M.P.A., HICPAC, Division
of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE,
Mailstop H16-3, Atlanta, Georgia 30329-4027, Telephone: (404) 718-8039;
Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion
(DHQP), the Director, National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), the Director, CDC, and the Secretary,
Department of Health and Human Services, regarding (1) the practice of
healthcare infection prevention and control; (2) strategies for
surveillance, prevention, and control of infections, antimicrobial
resistance, and related events in settings where healthcare is
provided; and (3) periodic updating of CDC guidelines and other policy
statements regarding prevention of healthcare-associated infections and
healthcare-related conditions.
Matters to be Considered: The agenda will include the following
updates: The Healthcare Personnel Guideline Workgroup; Isolation
Precautions Guideline Workgroup; NHSN workgroup; and Dental Unit
Waterlines Guideline Update. Agenda items are subject to change.
Public Participation
Oral Public Comment: This meeting will include time for members of
the public to make an oral comment. Priority will be given to
individuals who submit a request to make an oral public comment before
the meeting according to the procedures below: All persons interested
in making an oral public comment at the June 6-7, 2024 HICPAC meeting
must submit a request between May 13, 2024, and May 24, 2024, at
https://www.cdc.gov/hicpac/meeting.html no later than 11:59 p.m., EDT,
May 22, 2024, according to the instructions provided on the HICPAC
website. If the number of persons requesting to speak is greater than
can be reasonably accommodated during the scheduled time, CDC will
conduct a lottery draw to determine the speakers for the scheduled
public comment session. CDC staff will notify individuals regarding
their request to speak by email on May 27, 2024.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
[[Page 33354]]
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-09090 Filed 4-26-24; 8:45 am]
BILLING CODE 4163-18-P
